175 related articles for article (PubMed ID: 28375712)
41. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ
Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173
[TBL] [Abstract][Full Text] [Related]
42. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
[TBL] [Abstract][Full Text] [Related]
43. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
44. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
45. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
[TBL] [Abstract][Full Text] [Related]
46. Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells.
Choi PW; Yang J; Ng SK; Feltmate C; Muto MG; Hasselblatt K; Lafferty-Whyte K; JeBailey L; MacConaill L; Welch WR; Fong WP; Berkowitz RS; Ng SW
Oncotarget; 2016 Jan; 7(4):4110-21. PubMed ID: 26684027
[TBL] [Abstract][Full Text] [Related]
47. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
Liu H; Ye H
Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
[TBL] [Abstract][Full Text] [Related]
48. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
[TBL] [Abstract][Full Text] [Related]
49. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
[TBL] [Abstract][Full Text] [Related]
50. Molecular changes in endometriosis-associated ovarian clear cell carcinoma.
Worley MJ; Liu S; Hua Y; Kwok JS; Samuel A; Hou L; Shoni M; Lu S; Sandberg EM; Keryan A; Wu D; Ng SK; Kuo WP; Parra-Herran CE; Tsui SK; Welch W; Crum C; Berkowitz RS; Ng SW
Eur J Cancer; 2015 Sep; 51(13):1831-42. PubMed ID: 26059197
[TBL] [Abstract][Full Text] [Related]
51. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
[TBL] [Abstract][Full Text] [Related]
52. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
53. Gene set-based analysis of mucinous ovarian carcinoma.
Chang CM; Wang PH; Horng HC
Taiwan J Obstet Gynecol; 2017 Apr; 56(2):210-216. PubMed ID: 28420510
[TBL] [Abstract][Full Text] [Related]
54. Profiling of selected angiogenesis-related genes in serous ovarian cancer patients.
Kuć P; Charkiewicz R; Klasa-Mazurkiewicz D; Milczek T; Mroczko B; Nikliński J; Laudański P
Adv Med Sci; 2017 Mar; 62(1):116-120. PubMed ID: 28235714
[TBL] [Abstract][Full Text] [Related]
55. Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins.
Cruz IN; Coley HM; Kramer HB; Madhuri TK; Safuwan NA; Angelino AR; Yang M
Cancer Genomics Proteomics; 2017 Jan; 14(1):35-51. PubMed ID: 28031236
[TBL] [Abstract][Full Text] [Related]
56. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
57. Identification of novel epithelial ovarian cancer biomarkers by cross-laboratory microarray analysis.
Jiang X; Zhu T; Yang J; Li S; Ye S; Liao S; Meng L; Lu Y; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):354-9. PubMed ID: 20556581
[TBL] [Abstract][Full Text] [Related]
58. Identification of molecular biomarkers for ovarian cancer using computational approaches.
Lalremmawia H; Tiwary BK
Carcinogenesis; 2019 Jul; 40(6):742-748. PubMed ID: 30753333
[TBL] [Abstract][Full Text] [Related]
59. PINA 3.0: mining cancer interactome.
Du Y; Cai M; Xing X; Ji J; Yang E; Wu J
Nucleic Acids Res; 2021 Jan; 49(D1):D1351-D1357. PubMed ID: 33231689
[TBL] [Abstract][Full Text] [Related]
60. Protein interaction network (PIN)-based breast cancer subsystem identification and activation measurement for prognostic modeling.
Lim S; Park Y; Hur B; Kim M; Han W; Kim S
Methods; 2016 Nov; 110():81-89. PubMed ID: 27329435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
